/
/
/

Ind-Swift Laboratories Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)373.10
Volume (₹)2.48 L
High (₹)373.10
Upper Circuit447.20
Low (₹)358.00
Lower Circuit298.20
Prev Close372.70
52W High (₹)389.50
Price363.00
52W Low (₹)87.15

Share Market Cap & Key Ratios Overview

M.Cap (₹)3237.58 Cr
Div. Yield (%)0.00
PE Ratio56.48
Debt to Equity0.03
Price to Book0.53
Book Value159.86
EPS (TTM)6.59
Face Value10.00
ROE (%)24.68

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
INDSWFTLABNSE
LTP
1W Low
1W High
Market cap (₹)
1904.4-15.6 (-0.81%)
1903.10
1984.80
4,56,833Cr
9183-56 (-0.61%)
9087
9467
2,45,426Cr
4907.5-142.5 (-2.82%)
4886.50
5066
1,87,320Cr
1136.3-54.7 (-4.59%)
1125.10
1187
1,13,217Cr
1390.1-33.4 (-2.35%)
1376.70
1426.10
1,12,212Cr
1857.4-81.1 (-4.18%)
1811.70
1949
1,01,155Cr
2121.9-49.6 (-2.28%)
2118.10
2192
97,626Cr
2350-32.9 (-1.38%)
2341.20
2419.20
96,859Cr
1162.9-15.1 (-1.28%)
1154.40
1179.90
96,406Cr
1652+6.7 (0.41%)
1622.60
1717
93,614Cr
363+0.08 (0.02%)
355.55
389.50
3,238Cr

Key Highlights of Ind-Swift Laboratories Ltd Balance Sheet

Ind-Swift Laboratories Ltd balance sheet discloses shareholders' funds of ₹68.74Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹68.74Cr, and the reserves and surplus of the company is ₹1021.24Cr.

The company has its non-current liabilities with total liabilities of ₹1377.42Cr as of 2025-03-31.

The current liabilities are ₹216.35Cr as of 2025-03-31. At the same time, current assets are ₹793.73Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹229.55Cr and tangible assets of ₹270.71Cr, provided in the Ind-Swift Laboratories Ltd financial statements.